BioNTech (BNTX) is down -20.3%, or -$20.69 to $81.47.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BNTX:
- Morning Movers: BioNTech sinks following departure of founders, Q4 results
- Options Volatility and Implied Earnings Moves Today, March 10, 2026
- BioNTech Posts 2025 Loss but Leans on Strong Cash and Late-Stage Oncology Pipeline
- BioNTech Co-Founders to Launch Independent mRNA Venture as Company Refocuses on Late-Stage Pipeline
- BioNTech reports Q4 adjusted EPS EUR (0.33) vs. EUR 1.79 last year